High affinity antibodies to human IL-6 receptor

Details for Australian Patent Application No. 2007254831 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Smith, Eric; Fandl, James P.; Rafique, Ashique; Stevens, Sean; Fairhurst, Jeanette L.; Papadopoulos, Nicholas J.; Karow, Margaret; Huang, Tammy T.; Martin, Joel H.; Pobursky, Kevin J.; Chen, Gang

Agent Watermark

Pub. Number AU-B-2007254831

PCT Pub. Number WO2007/143168

Priority 60/843,232 08.09.06 US; 60/810,664 02.06.06 US

Filing date 1 June 2007

Wipo publication date 13 December 2007

Acceptance publication date 22 March 2012

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/143168 Priority application(s): WO2007/143168

22 March 2012 Application Accepted

  Published as AU-B-2007254831

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007254834-Pulse width driving method using multiple pulse

2007254827-Compositions and methods for ameliorating hyperlipidemia